MOREEN BESWICK BOZIER: Open Payments
NPI 1871994244 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 24 payments from 7 companies in 2025. Trend: 2023 $139 · 2024 $146 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $215 |
| Daiichi Sankyo Inc. | 6 | $125 |
| Merck Sharp & Dohme LLC | 1 | $113 |
| Stemline Therapeutics Inc. | 2 | $51 |
| Genentech USA, Inc. | 2 | $38 |
| Syndax Pharmaceuticals, Inc. | 1 | $21 |
| JAZZ PHARMACEUTICALS INC. | 1 | $18 |
Products named: KISQALI, Enhertu, KEYTRUDA, Orserdu, REVUFORJ, Phesgo, Itovebi, ZEPZELCA.
Industry payments across NY — which companies pay providers there.
